Aims: To assess the postoperative morbidity and mortality, length of stay and long-term survival after resection of carcinoma of the oesophagus and gastro-oesophageal junction, after establishment of a new surgical team unit between thoracic and gastroenterologic surgeons. Methods: We analysed the prospective collected data of 166 consecutive patients who underwent a transthoracic oesophageal resection between June 1997 and December 2003. Results: There were 119 men and 47 women. The median age was 63 years (range 36-81). Fifty-five patients (33 %) had squamous cell carcinoma and 111 (67 %) had adenocarcinoma. Postoperative complications occurred in a total of 60 patients (36 %). Ten patients (6 %) died postoperatively, eight (4.8 %) due to medical and two (1.2 %) due to surgical complications. The median postoperative length of stay was 11 days (range 6-75). The overall 3-and 5-years survival was 35.6 % and 30.6 % respectively. Survival was adversely affected by patient age and tumor stage.
INTRODUCTION
Worldwide both medical and surgical gastroenterologists, general and thoracic surgeons, otologists and oncologists have treated carcinoma of the oesopha-gus and gastro-oesophageal junction. Mainly because of an insufficient cooperation the diagnostic and therapeutic points of view have varied among the different specialists. In continuation of this the fate of the patients varies according to the method of diagnosis and preoperative evaluation as well as to the criteria for risk scoring, resection, adjuvant therapy and palliation. Furthermore, increasing evidence shows that the hospital death rate is related to both surgical volume and personal experience (1-5). Recently, this is substantied in at least three studies, which demonstrated a significant association between hospital volume and quality (2, 6, 7) with a respective 2.9-, 3.7-and 5-fold decrease in hospital mortality at high volume hospitals.
It therefore seems logical that concentration of therapy to surgeons with special interest and education may also improve outcomes.
Thus, at our university hospital it was decided that a dedicated team of specialists in thoracic and gastrointestinal surgery as well as in thoracic anaesthesiology should take care of the operative procedure and the postoperative care of patients with carcinoma of the oesophagus and gastro-oesophageal junction. Furthermore, this should provide an opportunity for centralization of the treatment of all the patients from our region.
The objective of the present study was to evaluate the quality of all transthoracic oesophageal resections carried out during the first 6,5-year period by assessing morbidity, mortality, length of hospital stay as well as the long-term survival. Furthermore, the mortality was compared to that in a cohort of patients operated during 1960-1984 at the Department of Thoracic Surgery (8).
MATERIAL AND METHODS
During a 6,5-year period (1th. June 1997 to 31th. December 2003) 333 patients with carcinoma of the oesophagus or the oesophagogastric junction were evaluated at the Center for Esophageal Cancer at Aarhus University Hospital in Denmark. The inclusion criteria for patients fit for operation were the presence of a histological confirmed and local resectable carcinoma of the mid -to -distal oesophagus or gastro-oesophageal junction (Siewerts type I and II (9)), with no evidence of distant metastasis. A total of 181 patients were selected for transthoracic resection with curative intent, and in 166 patients resection was actually performed (all-over resection rate of 92 %). Fourteen out of fifty-five patients with squamous cell carcinoma underwent neoadjuvant chemoradiation therapy with concomitant 5-fluorouracil and 45 Gy radiation. Data from all patients were entered prospectively into a computerized database. However, only data from the 166 consecutive resected patients are presented in this study.
The preoperative staging and evaluation consisted of endoscopy with biopsy, computed tomography (CT) of the chest and abdomen, endoscopic ultrasonography (EUS) of the esophagus and laparoscopic ultrasonography (LUS) of the abdomen.
SURGICAL TECHNIQUE
The operative procedure was performed in close collaboration between two specialists and consultants in respective thoracic and gastrointestinal surgery. Anaesthesia was provided by one consultant anaesthetists with a special interest in thoracic anaesthesia.
For pain treatment peri-and postoperatively all patients had a thoracic epidural catheter (Th7-Th8). Surgery consisted of an en bloc esophagectomy, using a separate upper abdominal incision with resection of the proximal stomach followed by a right-sided anterior thoracotomy (partly muscle sparing). The esophagus was transected around the level of the azygos vein with a free margin of at least 5 cm. The stomach was used as conduit for esophageal replacement, and was completely mobilised with preservation of the right gastric and right gastroepiploic vessels. A Kocher maneuver was performed and the line of gastric transection extended from the low lesser curvature to the gastric fundus. Either a pyloromyotomy or a Heineke-Mikulicz pyloroplasty was used as a gastric drainage procedure. A circular stapling device (CEEA stapler, Autosuture) of cartridge 25, 28 or 31 mm was used for construction of the oesophagogastrostomy. The anastomose was covered with a pleural flap.
Lymphadenectomy comprised a two-field lymphadenectomy (mediastinum and upper abdomen) with a standard removal of all lymphatic tissue in the lower mediastinum (the paraesophageal and subcarinal nodal groups as well as the nodes along the rigth and left main bronchial tree) and along the cardia, along the lesser and greater curvature, along the left gastric artery, and along the hepatic and splenic artery to the celiac trunk and around the celiac trunk. In addition all the retroperitoneal tissue that lies over the right and left crus of the diaphragm as well as the tissue and lymph nodes overlying the adrenal gland was removed. Preservation of the spleen was always intended.
Postoperatively all patients had a jejunal feeding tube, either as a surgical jejunostomy (n = 26) or a manually guided naso-jejunal tube (n = 140) placed after completing the anastomoses. Standard enteral nutrition was initiated on the day of operation and continued until a sufficient peroral caloric intake was obtained. Peroral intake was allowed from the third postoperative day and intended to be complete at the sixth to seventh postoperative day.
All patients were extubated in the operating theatre before leaving to the recovery room. On the first day after surgery, 90 % of the patients went to the stationary ward whereas 10 % considered to have poor cardiopulmonary reserves or where surgery had been complicated by intraoperative events, went to the intensive care unit (ICU). OUTCOME DATA Surgical data, including duration of operation, blood loss and amounts of transfusion were registrated in the database. Resection was defined as palliative when residual tumor was confirmed after resection, or when there was a direct tumor invasion of nonresectable adjacent organs. Tumors were assigned according to the TMN classification (10) . Surgical outcomes, defined as postoperative complications, postoperative mortality, and length of hospital stay, were likewise registrated. Complications were classified as medical or surgical. Medical complications included cardiac, pulmonary, renal and/or hepatic failure, and stroke. Surgical complications included anastomotic leakage, nonanastomotic leakage, perforation or gangrene of the conduit, complications related to the feeding tube, chylothorax, haemorrhage and intraabdominal sepsis. Postoperative mortality was defined as any death during the first 30 days after operation or during the same hospitalisation. After recovering from surgery many patients had a convalescence period at an offsite medical facility for social reasons. Any death occurring during the convalescence was recorded as hospital death.
All patients were seen at the outpatient clinic at intervals of three months during the first year and every six months for one more year and every year for three more years.
Survival status was obtained from the medical records and verified through the Danish Central Personal Registry. All patients were followed from the date of surgery until death or 30th June 2004, whichever came first.
STATISTICAL ANALYSIS
Statistical analysis included chi-square test to compare differences in patient characteristics whereas continuous var-iables were compared by the Mann-Whitney test. To exclude the influence of early postoperative death on longterm survival, the first postoperative months was excluded from survival analysis. Survival curves were constructed by the Kaplan-Meier method, and compared with Logrank tests. The study population was stratified according to possible predictor variables, including age, sex, tumor type, stage, duration of operation and hospital stay. We also fitted proportional hazards regression models to identify predictors of survival, and to estimate adjusted ratios for risk of death and associated 95 % confidence intervals (CI). Statistical significance was accepted at the 5%level. Statistical analyses were performed with the use of SAS software (version 8.2 SAS Institute, North Carolina). The median duration of surgery (skin to skin) was 170 min (range 125-375) and the median blood loss was 600 ml (range 140-2650). Two patients had a leakage of the gastro-oesophageal anastomoses ( Table 1) and none of these died. Two patients evolved necrosis of the interposition and one of these died due to severe sepsis (Table  2) . Feeding tube complications occurred in two patients with a surgical jejunostomi and resulted in severe small bowel necrosis and peritonitis with one death due to intraabdominal infection and sepsis (Table 2) .
RESULTS

LENGTH OF STAY
For the 156 patients, who were discharged, the median length of stay was 11 days (range 6-75) but it was significantly longer in patients with postoperative complications (14 days (range 8-75)) than in patients without (10 days (range 6-22)) (p <0.01). In patients >65 years of age the median stay of length was 11 days (range 6-60) compared to 10 days (range 6-75) in patients <65 years. SURVIVAL The overall 1-, 3-, and 5-year survival rates for all 156 discharged patients were 69.6 %, 35.6 and 30.6 % and the median survival was 24 months (95 % CI: 19-30 months). Thirteen of the patients receiving neoadjuvant chemoradiation were discharged and the median survival in these were 25 months (NS). Clear trends in survival with respect to stage and age are shown in Figs 1 and 2, and Cox regression analysis also identified low pTMN stage (I and IIa) and age <65 yr as favorable predictors of survival (Table 3) . Furthermore, a trend towards improved survival was seen in patients with length of stay (LOS) <11 days 
DISCUSSION
This study demonstrates for patients who were fit to undergo resection of the oesophagus and gastro-oesophageal junction improvement of outcome compared to a cohort of patients operated in a previous 25 year period at the same university hospital (8). Furthermore, outcomes in term of morbidity and mortality were comparable to results obtained in other experienced Western series (11) (12) (13) (14) . The patients in this study represented a selected group of patients across a large region in Denmark. The series was selected due to the nature of our referral practice and due to the consecutive analysis of only patients undergoing transthoracic oesophagectomy. Improvement in surgical results over time has among others been attributed to changes in patient selection, staging procedures and surgical technique. Comparison of the present study to a cohort of 481 patient operated during 1960-1984 and also having a transthoracic oesophagectomy (8) revealed a marked decrease in hospital mortality from 19 % to 6%. In the period between 1984 and 1997 patients were operated both at the Department of thoracic surgery as well as at the Department of gastrointestinal surgery. No published data appear from this period. However, in the previous study (8) the mortality varied between 13 % in macroscopic radical resected patients and 27 % in palliative resected. A high frequency of palliative resections reflected a substantial difference in preoperative staging procedures as well as a more aggressive approach to surgery years ago. Moreover, we think that comparison to the previous series underline the importance of surgeon versus team-related variables. Surgeon-related factors include technical expertise, including judgement of when to operate whereas team-related factors include the quality of anaesthesia as well as the postoperative treatment and observation that identify complications early. Experience and training of the surgeon as well as the physiological status of the patient have been recognized as major risk factors affecting the mortality rate after oesophagectomy (12, 15, 16, 17) . During the study period the hospital mortality rate at our center was comparable to that of several other reports published from Western surgical centers during the same period (12, 13, 16, 18) , and a gradual decrease in mortality was observed during the study period at all centers. In the study of Birkmeyer et al (2) mortality rates after oesophagectomy in "low-volume" hospitals still exceeded 20 % and even in "high-volume" hospitals the mortality was up to 8.4 %. Many of these deaths were due to surgical complications. In our study the overall frequency of surgical complications was 12.7 %. Anastomotic leakage appeared in two patients (1.2 %) with no death. This percentage is among the lowest compared to other series (12, 13, 16, 18) , and the objection could be raised that we did not test for leakage as a postoperative routine. However, all patients started enteral feeding at the day of operation and oral intake at the third postoperative day without any clinical signs of anastomotic leakage. The most serious surgical complications were necrosis of the gastric graft and bowel necrosis due to the surgical jejunostomy. As a consequence of the latter we stopped the formation of a surgical jejunostomony and placed a naso-jejunal tube. No complications were observed due to this and the total mortality due to surgical complications was only 1.2 %.
Other commonly reported postoperative complications and causes of death have been pulmonary and cardiac. A detailed preoperative cardiac and pulmonary evaluation was therefore recommended in every patient considered for esophagectomy. In the present series 24.7 % of the patients developed medical complications and the total hospital mortality due to medical complications was 4.8 %. For that reason we still need to optimise preoperative evaluation and postoperative care.
We also observed relationships between postoperative complications and length of stay as well as an impact on long-term survival. Both medical and surgical complications were associated with longer stays. Length of stay was not affected by patient age. The low clinical impact of surgical complications fa-vours a timely intervention that kept the complications from being a major problem. Hence, when comparing surgeon-related outcome with outcomes reported in the literature (2, 19, 20) the low frequency of postoperative surgical complications could be possible explanations for the low length of stay and low mortality. In this a way a median length of hospital stay <11 days could be a good benchmark for ensuring quality. Furthermore, the influence of length of stay on long-term survival may as in other studies be identified as an independent prognostic factors after oesophagectomy (21) .
However, the overall long-term survival followed resection for oesophageal carcinoma remains low. Our overall 3-and 5-year survival rate was 35.6 % and 30.6 %. Like in other studies (20) we found survival related to tumor stage and patient age. In the 70 % of patients who had N1 disease (stage IIb, III or IV) the 3-and 5-year survival was disappointing although not different from that in most other recently reported studies (13, 22) . Likewise is the poorer survival in patients above 65 years of age (20) .
Recent randomised trials (23, 24) demonstrated improved survival in patients undergoing oesophageal resection combined with neoadjuvant treatment. Only few patients in the present study had neoadjuvant treatment and nothing can be concluded from our data. Furthermore, our treatment was most properly not sufficient as we used Fluorouracil and no induction therapy with Cisplastin as recommended in other studies (23, 24) . However, further randomised studies are needed to clarify these problems.
In conclusion, our data show, that reserving oesophagectomy for carcinoma in the oesophagus and gastro-oesophageal junction to a specialized surgical team unit at a high volume center, involving both gastrointestinal and thoracic surgeons operating in a common team, as well as anaesthetists, specialised in thoracic procedures, results in increased expertise and specialization of the team. Thereby the oesophageal resection becomes a safe procedure with low morbidity and mortality.
